07:00 , May 11, 2015 |  BC Week In Review  |  Company News

Celexion, Agenus deal

Agenus purchased Celexion’s Secant yeast display discovery platform to generate mAbs, the company’s IgG antibody library, technology to discover molecules targeting cell membrane-associated antigens and other related IP. Celexion received $1 million in cash and...